Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Virupakshappa Cb"'
Autor:
Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa CB
Publikováno v:
Diagnostics, Vol 13, Iss 13, p 2221 (2023)
Tumour sampling is indispensable to diagnostic and therapeutic decision making. Thus, 18F-FDG PET/CT has the potential to accurately discriminate between viable and non-viable tissues due to its ability to characterise the metabolism of visible tissu
Externí odkaz:
https://doaj.org/article/a53148a1b8f04a6fbe601b31facf752c
Autor:
Parul Thakral, Divya Manda, Subha Shankar Das, Pankaj Tandon, Virupakshappa CB, Dharmender Malik, Ishita Sen
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:8-14
Autor:
Divya, Manda, Parul, Thakral, Ishita, Sen, Subha Shankar, Das, Virupakshappa, Cb, Dharmender, Malik
Publikováno v:
Clinical Nuclear Medicine.
Differentiating infection and sterile inflammation is the main clinical concern of clinicians as they are closely related to each other. Although 18 F-FDG PET/CT imaging is widely used, its main disadvantage is its lack of specificity to discriminate
Autor:
Parul, Thakral, Divya, Manda, Subha Shankar, Das, Pankaj, Tandon, Virupakshappa, Cb, Dharmender, Malik, Ishita, Sen
Publikováno v:
Cancer biotherapyradiopharmaceuticals.
Autor:
Subha Shankar Das, Dharmender Malik, Ishita Sen, Divya Manda, Virupakshappa Cb, Parul Thakral
Publikováno v:
Clinical Nuclear Medicine. 47:e167-e169
Prostatic malignancy is the most common type of nonskin cancer and associated with significant morbidity and mortality. Early androgen deprivation therapy (ADT) is the treatment of choice in metastatic prostate cancer, whereas ADT delays progression
Autor:
Virupakshappa Cb, Parul Thakral, Subha Shankar Das, Dharmender Malik, Ishita Sen, Divya Manda
Publikováno v:
Clinical Nuclear Medicine
Occurrence of invasive fungal infections has gained significant attention during recent times in patients with COVID-19. Patients with severe form of COVID-19, such as those treated in the intensive care unit with prolonged steroid use, are particula
Autor:
Dharmender Malik, Divya Manda, Virupakshappa Cb, Parul Thakral, Subha Shankar Das, Ishita Sen
Publikováno v:
Nucl Med Mol Imaging
Laparoscopic resection of tumor is often performed for benign and small insulinomas, or for those located in the body or tail of the pancreas. The precise preoperative and intraoperative localization of the insulinoma is critical to minimize the surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a04b41c31b98da1bced3c00309e618
https://europepmc.org/articles/PMC8517054/
https://europepmc.org/articles/PMC8517054/
Autor:
Ishita Sen, Virupakshappa Cb, Parul Thakral, Subha Shankar Das, Divya Manda, Dharmender Malik
Publikováno v:
Br J Radiol
Objective: The aim of the present study was to perform calculation of the absorbed doses to organs at risk and to neuroendocrine tumors and to determine whether hepatic intra-arterial (IA) injection of 177Lu-DOTATATE Peptide Receptor Radionuclide The
Autor:
Thakral P; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, Haryana, India., Sen IB; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, Haryana, India., Das SS; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, Haryana, India., Schultz MK; Division of Nuclear Medicine, University of Iowa, Iowa, IA, USA., Kumari J; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, Haryana, India., Virupakshappa CB; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, Haryana, India., Malik D; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, Haryana, India.
Publikováno v:
Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India [Indian J Nucl Med] 2024 Mar-Apr; Vol. 39 (2), pp. 142-143. Date of Electronic Publication: 2024 May 29.
Autor:
Thakral P; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India., Das SS; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India., Dhiman S; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India., Manda D; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India., Virupakshappa CB; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India., Malik D; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India., Sen I; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India.
Publikováno v:
Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Sep; Vol. 38 (7), pp. 468-474. Date of Electronic Publication: 2023 Apr 21.